Comparative study of clarithromycin and penicillin V in the treatment of streptococcal pharyngitis

1991 ◽  
Vol 10 (11) ◽  
pp. 949-953 ◽  
Author(s):  
G. E. Stein ◽  
S. Christensen ◽  
N. Mummaw
Keyword(s):  
Comparative Study ◽  
Streptococcal Pharyngitis ◽  
Penicillin V

A double-blinded comparative study of sultamicillin and potassium penicillin V in the treatment of childhood streptococcal pharyngitis*

1984 ◽  
Vol 14 (3) ◽  
pp. 261-265 ◽  
Author(s):  
Stephen C. Aronoff ◽  
Jeffrey D. Klinger ◽  
Cheryl A. O'Brien ◽  
Arthur C. Jaffe ◽  
Jeffrey L. Blumer
Keyword(s):  
Comparative Study ◽  
Streptococcal Pharyngitis ◽  
Penicillin V ◽  
Potassium Penicillin ◽  
Double Blinded

Randomized, Single-Blinded Comparative Study of the Efficacy of Amoxicillin (40 mg/kg/day) Versus Standard-Dose Penicillin V in the Treatment of Group a Streptococcal Pharyngitis in Children

1998 ◽  
Vol 37 (6) ◽  
pp. 341-346 ◽  
Author(s):  
Ishwar Gopichand ◽  
Gary D. Williams ◽  
Carla Saracusa ◽  
Sharon V. Medendorp ◽  
Camille Sabella ◽  
...  
Keyword(s):  
Comparative Study ◽  
Standard Dose ◽  
Streptococcal Pharyngitis ◽  
Penicillin V ◽  
Group A

Comparative Study of Cefetamet Pivoxil and Penicillin V in the Treatment of Group A Beta-Hemolytic Streptococcal Pharyngitis

Chemotherapy ◽  
1992 ◽  
Vol 38 (2) ◽  
pp. 33-37 ◽  
Author(s):  
J. Ramet ◽  
D. Pierard ◽  
P. Vandenberghe ◽  
K. De Boeck
Keyword(s):  
Comparative Study ◽  
Streptococcal Pharyngitis ◽  
Penicillin V ◽  
Group A

ERYTHROMYCIN PROPIONATE AND POTASSIUM PENICILLIN V IN THE TREATMENT OF GROUP A STREPTOCOCCAL PHARYNGITIS

PEDIATRICS ◽  
1963 ◽  
Vol 31 (1) ◽  
pp. 22-28
Author(s):  
Maxwell Stillerman ◽  
Stanley H. Bernstein ◽  
Martha Smith ◽  
Jack D. Gorvoy
Keyword(s):  
Relative Effectiveness ◽  
Streptococcal Pharyngitis ◽  
Group A Streptococci ◽  
Cure Rate ◽  
Acute Pharyngitis ◽  
Penicillin V ◽  
Daily Dose ◽  
Group A ◽  
Potassium Penicillin

The relative effectiveness of erythromycin propionate and K penicillin V in two dosage schedules was evaluated in the treatment of 261 cases of acute pharyngitis from which Group A hemolytic streptococci were recovered from December, 1958, to June, 1959. Erythromycin propionate, in a daily dose of 30 mg/kg up to 1.0 gm, and K penicillin V, in daily doses of 375 mg and 750 mg, were administered orally for 10 days. The adjusted bacterial cure rate was 78% among 86 patients treated with erythromycin, 72% among 102 patients treated with K penicillin V, 375 mg, and 88% among 73 patients treated with K penicillin V, 750 mg. The data indicate that K penicillin V was more effective in eradicating Group A streptococci from the pharynx in a daily dose of 750 mg than 375 mg, and suggest that erythromycin propionate in the dosage used, was less effective than K penicillin V, 750 mg, but equally as effective as K penicillin V, 375 mg daily. The incidence, time of occurrence, and results of retreatments of bacterial relapses are presented, and two possible causes of relapses are considered.

scholarly journals Comparative efficacy and safety of 3-day azithromycin and 10-day penicillin V treatment of group A beta-hemolytic streptococcal pharyngitis in children.

1996 ◽  
Vol 40 (4) ◽  
pp. 1005-1008 ◽  
Author(s):  
L Pacifico ◽  
F Scopetti ◽  
A Ranucci ◽  
M Pataracchia ◽  
F Savignoni ◽  
...  
Keyword(s):  
Clinical Success ◽  
Streptococcal Pharyngitis ◽  
Efficacy And Safety ◽  
Comparative Efficacy ◽  
Once Daily ◽  
Penicillin V ◽  
Oral Regimen ◽  
Beta Hemolytic Streptococcus ◽  
Group A

The efficacy and safety of a 3-day course of azithromycin oral suspension (10 mg/kg of body weight once daily) were compared with those of penicillin V (50,000 U/kg/day in two divided doses) in children aged 3 to 12 years for the treatment of symptomatic pharyngitis caused by the group A beta-hemolytic streptococcus (GABHS). For the 154 evaluable patients, the original infecting strain of GABHS was eliminated at the end of follow-up (34 to 36 days after treatment started) from 67 (85.8%) of 78 penicillin-treated patients and 41 (53.9%) of 76 azithromycin-treated patients (P < 0.0001). Overall clinical success was achieved in 71 (91.0%) of 78 penicillin V-treated patients and 57 (75.0%) of 76 azithromycin-treated patients (P < 0.05). Potential drug-related adverse events were reported for 5.5 and 8.6% of the penicillin V- and azithromycin-treated patients, respectively (P = 0.6). In the present study, a once-daily (10 mg/kg), 3-day oral regimen of azithromycin was as safe as a 10-day course of penicillin but did not represent an effective alternative to penicillin for the treatment of GABHS pharyngitis, even for those children with azithromycin-susceptible strains.

Sign in / Sign up

Export Citation Format

Share Document